scholarly journals Epinephrine administration in venoarterial extracorporeal membrane oxygenation patients is associated with mortality: a retrospective cohort study

2021 ◽  
Author(s):  
Nicolas Massart ◽  
Alexandre Mansour ◽  
James T. Ross ◽  
Claude Ecoffey ◽  
Caroline Aninat ◽  
...  
Keyword(s):  
Cohort Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Epinephrine Administration ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation

Predictors of complications related to venoarterial extracorporeal membrane oxygenation in adults: A multicenter retrospective cohort study

Heart & Lung ◽  
2020 ◽  
Vol 49 (1) ◽  
pp. 60-65
Author(s):  
Gislaine Rodrigues Nakasato ◽  
Beatriz Murata Murakami ◽  
Maria Aparecida Batistão Gonçalves ◽  
Juliana de Lima Lopes ◽  
Camila Takao Lopes
Keyword(s):  
Cohort Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation

The effects of propofol on extracorporeal membrane oxygenation oxygenator exchange

2021 ◽  
pp. 039139882110160
Author(s):  
Kelsey L Browder ◽  
Ayesha Ather ◽  
Komal A Pandya
Keyword(s):  
Cohort Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Cumulative Dose ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Primary Outcome ◽  
Ecmo Support ◽  
Single Center ◽  
Membrane Oxygenation ◽  
Vv Ecmo

The objective of this study was to determine if propofol administration to veno-venous (VV) extracorporeal membrane oxygenation (ECMO) patients was associated with more incidents of oxygenator failure when compared to patients who did not receive propofol. This was a single center, retrospective cohort study. The primary outcome of the study is oxygenator exchanges per ECMO day in patients who received propofol versus those who did not receive propofol. Patients were 18 years or older on VV-ECMO support between January 1, 2015 and January 31, 2018. Patients were excluded if they required ECMO support for less than 48 h or greater than 21 days. There were five patients in the propofol arm that required oxygenator exchanges and seven patients in the control arm. The total number of oxygenator exchanges per ECMO day was not significantly different between groups ( p = 0.50). When comparing those who required an oxygenator exchange and those who did not, there was no difference in the cumulative dose of propofol received per ECMO hour (0.64 mg/kg/h vs 0.96 mg/kg/h; p = 0.16). Propofol use in patients on VV-ECMO does not appear to increase the number of oxygenator exchanges.

scholarly journals Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study

Critical Care ◽  
2014 ◽  
Vol 18 (1) ◽  
pp. R38 ◽  
Author(s):  
Darryl Abrams ◽  
Jeffrey Javidfar ◽  
Erica Farrand ◽  
Linda B Mongero ◽  
Cara L Agerstrand ◽  
...  
Keyword(s):  
Cohort Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Early Mobilization ◽  
Membrane Oxygenation
Sign in / Sign up

Export Citation Format

Share Document